Article Versions Notes

Salmon J-H, Letarouilly J-G, Goëb V, Kanagaratnam L, Coquerelle P, Guyot M-H, Houvenagel E, Lecuyer N, Marguerie L, Morel G, et al. Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network. Journal of Clinical Medicine. 2020; 9(5):1528. https://doi.org/10.3390/jcm9051528

Salmon, Jean-Hugues, Jean-Guillaume Letarouilly, Vincent Goëb, Lukshe Kanagaratnam, Pascal Coquerelle, Marie-Hélène Guyot, Eric Houvenagel, Nicolas Lecuyer, Laurent Marguerie, Gauthier Morel, and et al. 2020. "Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network" Journal of Clinical Medicine 9, no. 5: 1528. https://doi.org/10.3390/jcm9051528

Salmon, J.-H., Letarouilly, J.-G., Goëb, V., Kanagaratnam, L., Coquerelle, P., Guyot, M.-H., Houvenagel, E., Lecuyer, N., Marguerie, L., Morel, G., Baudens, G., Gervais, E., & Flipo, R.-M. (2020). Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network. Journal of Clinical Medicine, 9(5), 1528. https://doi.org/10.3390/jcm9051528